15-51499362-A-G
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_001378457.1(DMXL2):āc.3862T>Cā(p.Ser1288Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.504 in 1,613,468 control chromosomes in the GnomAD database, including 206,286 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001378457.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DMXL2 | NM_001378457.1 | c.3862T>C | p.Ser1288Pro | missense_variant | 18/44 | ENST00000560891.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DMXL2 | ENST00000560891.6 | c.3862T>C | p.Ser1288Pro | missense_variant | 18/44 | 1 | NM_001378457.1 | A1 | |
DMXL2 | ENST00000543779.6 | c.3862T>C | p.Ser1288Pro | missense_variant | 18/43 | 1 | P4 | ||
DMXL2 | ENST00000251076.9 | c.3862T>C | p.Ser1288Pro | missense_variant | 18/43 | 1 | A1 | ||
DMXL2 | ENST00000449909.7 | c.2765-4228T>C | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.490 AC: 74459AN: 151852Hom.: 18548 Cov.: 32
GnomAD3 exomes AF: 0.492 AC: 123222AN: 250686Hom.: 30852 AF XY: 0.488 AC XY: 66164AN XY: 135588
GnomAD4 exome AF: 0.506 AC: 739086AN: 1461498Hom.: 187719 Cov.: 55 AF XY: 0.503 AC XY: 366016AN XY: 727048
GnomAD4 genome AF: 0.490 AC: 74527AN: 151970Hom.: 18567 Cov.: 32 AF XY: 0.489 AC XY: 36348AN XY: 74280
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 81 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Polyendocrine-polyneuropathy syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Hearing loss, autosomal dominant 71 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at